We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Defeat Leaves Molecular Scar in Brain

By Biotechdaily staff writers
Posted on 15 Mar 2006
Researchers studying a mouse model of depression found that repeated defeat by dominant animals leaves a mouse with an enduring molecular scar in its brain, which may help to explain why depression is so difficult to cure.

In the mouse model, silencer molecules turned off a gene for a key protein in the brain's hippocampus. More...
After activating a compensatory mechanism, an antidepressant was able to temporarily restore the animal's sociability and the protein's expression but failed to remove the silencers. A true cure for depression would probably have to target this scar, according to the researchers, from the University of Texas Southwestern Medical Center (Dallas, TX, USA). Their findings were reported in the February 26, 2006, online edition of Nature Neuroscience.

Mice exposed to aggression by a different dominant mouse daily for 10 days became socially defeated and strongly avoided other mice, even weeks later. The expression of a representative gene in the hippocampus, a memory center implicated in depression, fell three-fold and remained suppressed for weeks. Chronic treatment with imipramine, a tricyclic antidepressant, restored expression of the gene for brain-derived neurotrophic factor (BDNF) to normal levels and reversed social withdrawal behavior.

The researchers traced the gene expression changes to long-lasting modifications in histones, which are proteins that regulate the turning on-and-off of genes via methylation. The drug imipramine was unable to remove these silencer molecules, suggesting that they remained as a latent source of vulnerability to future stress.

"The molecular scar induced by chronic stress in the hippocampus, and perhaps elsewhere in the brain, can't easily be reversed,” noted lead researcher Eric Nestler, M.D., of the Southwestern Medical Center. "To really cure depression, we probably need to find new treatments that can remove the silencer molecules.”



Related Links:
U. Texas Southwestern Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
Automated Urinalysis Solution
UN-9000
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.